Showing results (81-90 of 1,033) with videos related to

Sort By:
Pageof 104
Journal of Thrombosis and Thrombolysis|May 6, 2023
Low dose rivaroxaban for the management of atherosclerotic cardiovascular diseasePlacido Maria Mazzone, Davide Capodanno
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 2, 2025
Late-Onset Device Related Thrombosis After Left Atrial Appendage Occlusion and Spleen Systemic Embolism: A Case ReportCostanza Agata Bordonaro, Davide Capodanno
Thrombosis and Haemostasis|July 29, 2010
Impact of race and gender on antithrombotic therapyDavide Capodanno, Dominick J Angiolillo
European Heart Journal. Cardiovascular Pharmacotherapy|August 10, 2021
Oral antithrombotic therapy for the prevention of recurrent cerebrovascular eventsDavide Capodanno, Dominick J Angiolillo
Current Treatment Options in Cardiovascular Medicine|October 22, 2011
Antithrombotic pharmacotherapy in the elderly: general issues and clinical conundrumsDavide Capodanno, Dominick J Angiolillo
Thrombosis and Haemostasis|December 19, 2014
Bivalirudin for acute coronary syndromes: premises, promises and doubtsDavide Capodanno, Raffaele De Caterina
Expert Review of Cardiovascular Therapy|March 9, 2016
Reviewing the controversy surrounding pre-treatment with P2Y12 inhibitors in acute coronary syndrome patientsDavide Capodanno, Dominick J Angiolillo
JACC. Cardiovascular Interventions|March 11, 2017
Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds: A Review of the Published Data, Practical Recommendations, and Future DirectionsDavide Capodanno, Dominick J Angiolillo
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 22, 2025
Long-term outcomes of percutaneous coronary intervention for recurrent events in patients undergoing target-vessel vs. nontarget-vessel revascularizationSimone Finocchiaro, Maria Sara Mauro, Claudio Laudani, et al.
JACC. Cardiovascular Interventions|August 13, 2025
Aspirin or P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention for Acute Coronary SyndromesClaudio Laudani, Daniele Giacoppo, Giovanni Occhipinti, et al.
Pageof 104